Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
CEL-SCI Stock Price, Quotes and Forecasts | AMEX:CVM | Benzinga
Explore CEL-SCI stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CVM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CEL-SCI (CVM) stock?
You can purchase shares of CEL-SCI (AMEX:CVM) through any online brokerage.
Who are CEL-SCI (CVM) competitors?
Other companies in CEL-SCI’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Sensei Biotherapeutics (NASDAQ:SNSE).
What is the forecast, or price target, for CEL-SCI (CVM) stock?
CEL-SCI has a consensus price target of $13.00.
What is the current price for CEL-SCI (CVM)?
The stock price for CEL-SCI (AMEX: CVM) is $2.47 last updated June 10, 2025 at 12:47 PM EDT.
Does CEL-SCI (CVM) pay a dividend?
There are no upcoming dividends for CEL-SCI.
When is CEL-SCI (AMEX:CVM) reporting earnings?
CEL-SCI’s Q3 earnings are confirmed for Thursday, August 14, 2025.
Is CEL-SCI (CVM) going to split?
There is no upcoming split for CEL-SCI.
What sector and industry does CEL-SCI (CVM) operate in?
CEL-SCI is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
